Brain gene therapy offers hope for kids with rare movement disorder

NCT ID NCT02852213

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 31 times

Summary

This study tests a one-time gene therapy for children with AADC deficiency, a rare genetic disorder that causes severe movement problems and developmental delays. The therapy delivers a working gene directly to the brain using a harmless virus. The goal is to improve motor function and reduce symptoms like eye-rolling episodes. The study is currently recruiting children aged 2 and older.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AADC DEFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Nationwide Children's Hospital

    RECRUITING

    Columbus, Ohio, 43205, United States

    Contact Email: •••••@•••••

    Contact

    Contact Email: •••••@•••••

    Contact

  • The Ohio State University Medical Center

    RECRUITING

    Columbus, Ohio, 43221, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

  • University of California San Francisco, Benioff Children's Hospital

    RECRUITING

    San Francisco, California, 94143, United States

    Contact Email: •••••@•••••

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.